Key terms
About MOR
MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MOR news
Yesterday
11:27am ET
MorphoSys Announces Barclays PLC’s Voting Rights Shift
May 02
11:27am ET
MorphoSys AG Reports Shift in Major Holdings
Apr 30
10:57am ET
Barclays PLC Acquires 10% Stake in MorphoSys AG
Apr 30
9:59am ET
MorphoSys AG Navigates Takeover and Asset Sale
Apr 30
4:35am ET
MorphoSys downgraded to Neutral from Outperform at Oddo BHF
Apr 29
5:00pm ET
MorphoSys AG Set for Novartis Acquisition
Apr 26
10:57am ET
MorphoSys AG Announces Shift in Major Holdings
Apr 25
12:00pm ET
MorphoSys AG Sees Shift in Major Shareholders
Apr 24
11:57am ET
MorphoSys AG Unveils Cancer Drug Trial Progress
Apr 24
10:57am ET
MorphoSys AG Shares Shift in Major Holdings
Apr 23
10:57am ET
MorphoSys AG Reports Major Shareholding Change
Apr 22
11:58am ET
Morgan Stanley Adjusts Stake in MorphoSys AG
Apr 19
10:57am ET
MorphoSys AG Reports Change in Major Holdings
Apr 18
11:27am ET
MorphoSys AG Reports Shift in Voting Rights
Apr 16
10:57am ET
MorphoSys Shareholding Shift with Barclays’ Increased Stake
Apr 12
11:57am ET
MorphoSys AG Reports Major Norwegian Stake
Apr 11
9:12am ET
MorphoSys board recommends shareholders accept Novartis offer
Apr 11
8:59am ET
MorphoSys Management, Supervisory board recommend Novartis takeover
Apr 09
10:57am ET
MorphoSys AG Reports Major Shareholding Change
Apr 08
10:57am ET
MorphoSys AG’s Ownership Shift: Goldman Sachs Acquires Stake
Apr 04
10:57am ET
Barclays PLC Adjusts Stake in MorphoSys AG
Apr 02
11:27am ET
MorphoSys AG Announces Capital Increase
Mar 27
1:57pm ET
MorphoSys AG Reports Major Shareholding Changes
Mar 26
11:57am ET
MorphoSys AG Reports Major Shareholding Change
Mar 25
11:57am ET
MorphoSys AG Reports Major Stake Change
Mar 22
11:57am ET
MorphoSys AG Reports Major Voting Rights Change
Mar 22
7:27am ET
MorphoSys Set for Novartis Takeover Post-U.S. Clearance
Mar 21
12:27pm ET
MorphoSys AG Announces Major Voting Rights Changes
Mar 20
4:57pm ET
MorphoSys’ Milestone Year Paves Way for Growth
Mar 20
12:27pm ET
MorphoSys AG Announces Shift in Shareholding
Mar 19
11:57am ET
MorphoSys AG Reports Major Voting Rights Change
No recent press releases are available for MOR
MOR Financials
Key terms
Ad Feedback
MOR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MOR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
